Key result
VA-ECMO successfully manages cardiogenic shock from pheochromocytoma-induced inverted Takotsubo cardiomyopathy as a bridge to adrenalectomy.
Case Report (n=1)
VA-ECMO can serve as a lifesaving bridge to pharmacological therapy and surgery in patients with cardiogenic shock due to pheochromocytoma-induced inverted Takotsubo-like cardiomyopathy.
May support VA-ECMO bridging in pheochromocytoma cardiomyopathy shock; single case leaves open need for prospective validation.
Pheochromocytoma is a rare neuroendocrine tumors which overproduce catecholamines and arise from the adrenal gland or extra-adrenal chromaffin cells of the sympathetic and parasympathetic ganglia. We report a case of pheochromocytoma-induced inverted Takotsubo-like cardiomyopathy leading to cardiogenic shock successfully managed with veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) as a bridge to pharmacological control and subsequent curative laparoscopic adrenalectomy.
No takes yet. Share an insight, caveat, or question.
Aziz et al. (2018) conducted a case report in Pheochromocytoma-induced inverted Takotsubo-like cardiomyopathy leading to cardiogenic shock (n=1). Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) was evaluated on Successful management as a bridge to pharmacological control and subsequent curative laparoscopic adrenalectomy. Veno-arterial extracorporeal membrane oxygenation (ECMO) successfully managed cardiogenic shock from pheochromocytoma-induced inverted Takotsubo-like cardiomyopathy as a bridge to adrenalectomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: